Inhaled fluticasone reduces sputum inflammatory indices in <font color="blue">severe_4</font> <font color="blue">bronchiectasis_5</font> <font color="blue">._5</font> 
<br>
<br> Although corticosteroid therapy might be clinically beneficial for <font color="blue">bronchiectasis_2</font> <font color="blue">,_2</font> very little is known of its effects on the inflammatory and infective markers in <font color="blue">bronchiectasis_1</font> <font color="blue">._1</font> We have therefore performed a double - blind , placebo - controlled study to evaluate the effects of a 4-wk administration of inhaled fluticasone in <font color="blue">bronchiectasis_1</font> <font color="blue">._1</font> <font color="blue">Twenty_7</font> <font color="blue">-_7</font> <font color="blue">four_7</font> <font color="blue">patients_7</font> <font color="blue">(_7</font> <font color="blue">12_7</font> <font color="blue">female_7</font> <font color="blue">;_7</font> <font color="blue">mean_7</font> <font color="blue">age_7</font> <font color="blue">51_7</font> <font color="blue">yr_7</font> <font color="blue">)_7</font> <font color="blue">were_3</font> <font color="blue">randomized_3</font> <font color="blue">into_2</font> <font color="blue">receiving_2</font> <font color="blue">either_2</font> <font color="blue">inhaled_2</font> <font color="blue">fluticasone_2</font> <font color="blue">(_2</font> <font color="blue">500_2</font> <font color="blue">microgram_2</font> <font color="blue">twice_2</font> <font color="blue">daily_2</font> <font color="blue">)_2</font> <font color="blue">via_2</font> <font color="blue">the_2</font> <font color="blue">Accuhaler_2</font> <font color="blue">device_2</font> <font color="blue">(_2</font> <font color="blue">n_2</font> <font color="blue">=_2</font> <font color="blue">12_2</font> <font color="blue">)_2</font> <font color="blue">or_2</font> <font color="blue">placebo_2</font> <font color="blue">._2</font> At each visit , spirometry , 24-h sputum volume , sputum leukocyte density , bacterial densities , and concentrations of interleukin ( IL)-1beta , IL-8 , tumor necrosis factor - alpha ( TNF - alpha ) , and leukotriene B4 ( LTB4 ) were determined . There was a significant ( p < 0.05 ) decrease in sputum leukocyte density and IL-1beta , IL-8 , and LTB4 after fluticasone treatment . The fluticasone group had one and the placebo group three episodes of exacerbation . There were no significant changes in spirometry ( p > 0.05 ) or any reported adverse reactions in either group . The results of this study show that high - dose fluticasone is effective in reducing the sputum inflammatory indices in <font color="blue">bronchiectasis_1</font> . Large - scale and long - term studies are indicated to evaluate the effects of inhaled steroid therapy on the inflammatory components in <font color="blue">bronchiectasis_2</font> <font color="blue">._2</font>